1. Home
  2. OVID vs GEOS Comparison

OVID vs GEOS Comparison

Compare OVID & GEOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • GEOS
  • Stock Information
  • Founded
  • OVID 2014
  • GEOS 1980
  • Country
  • OVID United States
  • GEOS United States
  • Employees
  • OVID N/A
  • GEOS N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • GEOS Industrial Machinery/Components
  • Sector
  • OVID Health Care
  • GEOS Industrials
  • Exchange
  • OVID Nasdaq
  • GEOS Nasdaq
  • Market Cap
  • OVID 88.9M
  • GEOS 72.9M
  • IPO Year
  • OVID 2017
  • GEOS 1997
  • Fundamental
  • Price
  • OVID $1.27
  • GEOS $17.35
  • Analyst Decision
  • OVID Strong Buy
  • GEOS
  • Analyst Count
  • OVID 4
  • GEOS 0
  • Target Price
  • OVID $3.13
  • GEOS N/A
  • AVG Volume (30 Days)
  • OVID 1.5M
  • GEOS 191.3K
  • Earning Date
  • OVID 11-11-2025
  • GEOS 08-07-2025
  • Dividend Yield
  • OVID N/A
  • GEOS N/A
  • EPS Growth
  • OVID N/A
  • GEOS N/A
  • EPS
  • OVID N/A
  • GEOS N/A
  • Revenue
  • OVID $6,651,000.00
  • GEOS $115,527,000.00
  • Revenue This Year
  • OVID $708.13
  • GEOS N/A
  • Revenue Next Year
  • OVID N/A
  • GEOS N/A
  • P/E Ratio
  • OVID N/A
  • GEOS N/A
  • Revenue Growth
  • OVID 1070.95
  • GEOS N/A
  • 52 Week Low
  • OVID $0.24
  • GEOS $5.51
  • 52 Week High
  • OVID $1.47
  • GEOS $21.60
  • Technical
  • Relative Strength Index (RSI)
  • OVID 55.01
  • GEOS 51.79
  • Support Level
  • OVID N/A
  • GEOS $16.10
  • Resistance Level
  • OVID $1.35
  • GEOS $17.29
  • Average True Range (ATR)
  • OVID 0.10
  • GEOS 1.21
  • MACD
  • OVID -0.07
  • GEOS -0.34
  • Stochastic Oscillator
  • OVID 93.78
  • GEOS 31.78

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

About GEOS Geospace Technologies Corporation (Texas)

Geospace Technologies Corp is engaged in designing and manufacturing seismic instruments and non-seismic equipment used in the oil and gas industry. The company has three different segments: oil and gas markets, adjacent markets, and emerging markets. The oil and gas markets segment, which accounts for the majority of the company's revenue, includes traditional exploration products, wireless exploration products, and reservoir characterization products and services. The adjacent markets business is closely tied to the oil and gas markets and includes imaging products and industrial products. The company operates globally across Asia, Canada, Europe, the United States, South America, Mexico, and other regions with a majority of its revenue being generated within the United States.

Share on Social Networks: